Seroprevalence of H7N9 infection among humans: A systematic review and meta-analysis
- PMID: 32157809
- PMCID: PMC7431636
- DOI: 10.1111/irv.12736
Seroprevalence of H7N9 infection among humans: A systematic review and meta-analysis
Abstract
In spring 2013, a novel avian-origin influenza A (H7N9) virus emerged in mainland China. The burden of H7N9 infection was estimated based on systematic review and meta-analysis. The systematic search for available literature was conducted using Chinese and English databases. We calculated the pooled seroprevalence of H7N9 infection and its 95% confidence interval by using Freeman-Tukey double arcsine transformation. Out of 16 890 records found using Chinese and English databases, 54 articles were included in the meta-analysis. These included studies of a total of 64 107 individuals. The pooled seroprevalence of H7N9 infection among humans was 0.122% (95% CI: 0.023, 0.275). In high-risk populations, the highest pooled seroprevalence was observed among close contacts (1.075%, 95% CI: 0.000, 4.357). The seroprevalence among general population was (0.077%, 95% CI: 0.011, 0.180). Our study discovered that asymptomatic infection of H7N9 virus did occur, even if the seroprevalence among humans was low.
Keywords: H7N9; influenza A; meta-analysis; seroprevalence; systematic review.
© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Gao RB, Cao B, Hu YW, et al. Human infection with a novel avian‐origin influenza A (H7N9) virus. N Engl J Med. 2013;368(20):1888‐1897. - PubMed
-
- World Health Organization . Human Infection with Avian Influenza A (H7N9) Virus – China: Update. https://www.who.int/csr/don/05‐september‐2018‐ah7n9‐china/en/. Accessed December 30, 2018.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
